Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 357

1.
2.

First case on fluorodeoxyglucose positron emission tomography/computerized tomography of a distant skip metastases to parotid node from esophageal adenocarcinoma.

Militano V, Muthu S, Farooq N, Sajjan R.

World J Nucl Med. 2018 Oct-Dec;17(4):302-304. doi: 10.4103/wjnm.WJNM_82_17.

3.

False-positive technetium-99m methylene diphosphonate bone scan activity in the orbit in a patient with a history of breast carcinoma.

Bonnet SE, Palko JR.

World J Nucl Med. 2018 Oct-Dec;17(4):299-301. doi: 10.4103/wjnm.WJNM_73_17.

4.
5.

Giant simple biliary cyst infection treated with minimally invasive percutaneous drainage.

Rocha RD, Falsarella PM, Pereira De Azevedo AA, Garcia RG.

World J Nucl Med. 2018 Oct-Dec;17(4):293-295. doi: 10.4103/wjnm.WJNM_63_17.

7.

Prostate-specific antigen cutoff value for ordering sodium fluoride positron emission tomography/computed tomography bone scan in patients with prostate cancer.

Sarikaya I, Sarikaya A, Elgazzar AH, Caloglu VY, Sharma P, Baqer A, Caloglu M, Alfeeli M.

World J Nucl Med. 2018 Oct-Dec;17(4):281-285. doi: 10.4103/wjnm.WJNM_87_17.

8.

Prognostic factors in breast cancer patients evaluated by positron-emission tomography/computed tomography before neoadjuvant chemotherapy.

Farrugia MK, Wen S, Jacobson GM, Salkeni MA.

World J Nucl Med. 2018 Oct-Dec;17(4):275-280. doi: 10.4103/wjnm.WJNM_84_17.

9.

The assessment of radio-adaptive response in graves' hyperthyroidism patients following radioactive iodine uptake.

Fazeli Z, Monfared AS, Zakavi SR, Amiri M, Zabihi E, Borzoueisileh S, Gholami A, Gorji KE.

World J Nucl Med. 2018 Oct-Dec;17(4):270-274. doi: 10.4103/wjnm.WJNM_83_17.

10.

Initial risk stratification and staging in prostate cancer with prostatic-specific membrane antigen positron emission tomography/computed tomography: A first-stop-shop.

Gupta M, Choudhury PS, Rawal S, Goel HC, Talwar V, Singh A, Sahoo SK.

World J Nucl Med. 2018 Oct-Dec;17(4):261-269. doi: 10.4103/wjnm.WJNM_79_17.

11.

Evaluation of the physical and biological dosimetry methods in iodine-131-treated patients.

Ozdal A, Erselcan T, Özdemir Ö, Özgüven Y, Silov G, Erdoğan Z.

World J Nucl Med. 2018 Oct-Dec;17(4):253-260. doi: 10.4103/wjnm.WJNM_78_17.

12.

Scintigraphic evaluation of colonic transit in children with constipation using 67Ga-citrate.

Calegaro JUM, Tajra JBM, Souto JFM, Marciano FR, De Landa DC, Bae SB, Filho HB.

World J Nucl Med. 2018 Oct-Dec;17(4):249-252. doi: 10.4103/wjnm.WJNM_75_17.

13.
14.
15.

Clinical utility of 188Rhenium-hydroxyethylidene-1,1-diphosphonate as a bone pain palliative in multiple malignancies.

Shinto AS, Mallia MB, Kameswaran M, Kamaleshwaran KK, Joseph J, Radhakrishnan ER, Upadhyay IV, Subramaniam R, Sairam M, Banerjee S, Dash A.

World J Nucl Med. 2018 Oct-Dec;17(4):228-235. doi: 10.4103/wjnm.WJNM_68_17.

16.

How comprehensive are nuclear medicine residency websites?

Plas TLV, Novin SA, Yi PH.

World J Nucl Med. 2018 Oct-Dec;17(4):223-227. doi: 10.4103/wjnm.WJNM_67_17.

17.
18.

Quantitative accuracy of positron emission tomography/magnetic resonance and positron emission tomography/computed tomography for cervical cancer.

Oldan JD, Khandani AH, Fielding JR, Jones EL, Gehrig PA, Sills TM, Roy P, Lin W.

World J Nucl Med. 2018 Oct-Dec;17(4):213-218. doi: 10.4103/wjnm.WJNM_56_17.

19.

Its goodbye from him.

Buscombe JR.

World J Nucl Med. 2018 Oct-Dec;17(4):211-212. doi: 10.4103/wjnm.WJNM_75_18. No abstract available.

20.

Fluorodeoxyglucose, sodium fluoride, and prostate-specific membrane antigen positron emission tomography studies for treatment response assessment in prostate cancer.

Sarikaya I, Elgazzar A, Sarikaya A, Alfeeli M.

World J Nucl Med. 2018 Jul-Sep;17(3):207-210. doi: 10.4103/wjnm.WJNM_51_17.

Supplemental Content

Loading ...
Support Center